台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    62.7
  • 漲跌
    ▼0.9
  • 漲幅
    -1.42%
  • 成交量
    94
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-富邦-南員林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-南員林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/13162.7000.0062.7011410.71%
2024/11/140.163.20262.0061.20-1.9138-1.35%
2024/10/1800.00264.1064.50-2166-1.20%
2024/10/16165.8000.0065.6011650.60%
2024/10/140.164.5000.0065.700.11600.08%
2024/10/07259.2000.0059.6021291.54%
2024/09/160.156.0000.0055.600.11570.09%
2024/08/27160.2000.0059.7011770.56%
2024/08/140.156.8000.0056.200.11930.07%
2024/08/07162.0000.0062.4011950.51%
2024/07/31265.3500.0064.6022320.86%
2024/07/170.163.2000.0063.000.12330.04%
2024/07/0500.00167.9067.50-1222-0.45%
2024/06/190.163.7000.0063.400.12210.04%
2024/06/06167.10166.6067.1002170.00%
2024/05/2100.00166.1066.30-1289-0.34%
2024/05/20167.80167.2067.9003070.00%
2024/05/17166.20167.0066.1003060.00%
2024/05/1500.00265.8065.20-2321-0.62%
2024/05/09167.5000.0067.1013130.32%
2024/05/0800.00164.4064.40-1299-0.33%
2024/05/07162.9000.0062.3012840.35%
2024/04/2900.00160.3060.30-1264-0.38%
2024/04/26160.50560.9060.30-4263-1.52%
2024/04/23161.60160.4060.7002550.00%
2024/04/2200.00157.7056.70-1248-0.40%
2024/03/0700.00257.2056.60-2245-0.81%
2024/02/29263.30264.1063.6002200.00%
2024/02/27166.1000.0064.3012160.46%
2024/02/2300.00164.5061.00-1202-0.49%
2024/02/21161.90160.3061.9001820.00%
2024/02/1600.00357.6357.20-3161-1.86%
2024/01/12153.3000.0051.6014300.23%
2024/01/0500.00250.8551.10-2416-0.48%
2024/01/02151.0000.0050.7014180.24%
2023/12/05150.5000.0049.9013850.26%
2023/12/0400.00151.3051.20-1382-0.26%
2023/11/24651.4000.0050.6063661.64%
2023/11/2100.00148.9049.05-1352-0.28%
2023/11/2000.00150.2049.35-1348-0.29%
2023/11/14250.9000.0051.0023330.60%
2023/11/10253.40155.0052.5013180.31%
2023/11/091356.43256.6053.50112983.68%
2023/11/07658.471158.9357.90-5256-1.95%
2023/11/06851.98454.5854.8042091.91%
2023/11/03954.301055.8152.00-1173-0.58%
2023/11/0100.00851.4951.90-877-10.32%
2023/10/31148.0000.0047.251561.76%
2023/10/30247.50548.7048.70-354-5.55%
2023/10/271445.2900.0045.55144034.16%
2023/10/24645.4000.0045.4564214.16%
2023/10/23346.2000.0045.903427.03%
2023/10/18245.3000.0045.502494.04%
2023/10/17545.4600.0045.505539.42%
2023/10/161645.5300.0045.70166723.73%
2023/09/28145.5000.0045.701711.39%
2023/09/27445.5400.0045.604725.49%
2023/09/26745.5500.0045.457729.60%
2023/09/25445.2300.0045.354745.37%
2023/09/22145.5000.0045.351741.35%
2023/09/21545.6400.0045.655746.72%
2023/07/27147.2000.0047.151721.38%
2023/07/20349.0500.0048.303654.59%
2023/07/1900.001147.8149.85-1162-17.55%
2023/07/1800.00747.0147.05-748-14.51%
2023/07/1200.002446.8546.55-2443-55.15%
2023/05/11145.0000.0044.501561.78%
2023/04/18446.7500.0046.354576.95%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章